Pierre Dubois, and Gökçe Gökkoca, “Antibiotic Demand in the Presence of Antimicrobial Resistance”, The Review of Economics and Statistics, 2026, forthcoming.
David Bardey, Philippe De Donder, and Vera Zaporozhets, “Economic Incentives to Develop and to Use Diagnostic Tests: A Litterature Review”, Journal of Economic Analysis, vol. 4, December 2025.
Helmuth Cremer, and Jean-Marie Lozachmeur, “Nonlinear reimbursement rules for preventive and curative medical care”, Journal of Health Economics, vol. 103, n. 103049, September 2025.
Matthew Adler, Maddalena Ferranna, James K. Hammitt, Eugénie de Laubier, and Nicolas Treich, “Fair Innings: An Empirical Test”, Health Economics, vol. 37, n. 7, July 2025, pp. 1350–1364.
David Bardey, and Philippe De Donder, “A Welfare Analysis of Genetic Testing in Health Insurance Markets with Adverse Selection and Prevention”, Canadian Journal of Economics, Toronto, vol. 58, n. 2, May 2025, pp. 443–483.
Philippe De Donder, “Introduction to the symposium on the economics of genetic testing and personalized medicine”, Canadian Journal of Economics, Toronto, vol. 58, n. 2, May 2025, pp. 414–417, Toronto.
Philippe De Donder, David Bardey, and Vera Zaporozhets, “The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests - A Literature Review”, Discover Health Systems, vol. 4, n. 26, April 2025.
Manh-Hung Nguyen, Viet-Ngu Hoang, Son Nghiem, and Lan Anh Nguyen, “The Dynamic and Heterogeneous Effects of COVID-19 Vaccination Mandates in the USA”, Health Economics, vol. 34, n. 3, March 2025, pp. 518–536.
Yassine Lefouili, Leonardo Madio, and Ying Lei Toh, “Privacy Regulation and Quality-Enhancing Innovation”, The Journal of Industrial Economics, vol. 72, n. 2, June 2024, pp. 662–684.